Silvant Capital Management’s Inspire Medical Systems INSP Stock Holding History

Silvant Capital Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,000	Closed	-$1.39M	–	304
2023 Q3	$1.39M	Hold	7,000	–	–	0.08%	133
2023 Q2	$2.27M	Hold	7,000	–	–	0.13%	104
2023 Q1	$1.64M	Hold	7,000	–	–	0.11%	118
2022 Q4	$1.76M	Buy	7,000 +4,690	+203%	+$1,000K	0.12%	111
2022 Q3	$410K	Hold	2,310	–	–	0.03%	155
2022 Q2	$422K	Sell	2,310 -1,033	-31%	-$206K	0.1%	103
2022 Q1	$858K	Hold	3,343	–	–	0.16%	96
2021 Q4	$769K	Sell	3,343 -214	-6%	-$52.3K	0.13%	107
2021 Q3	$828K	Sell	3,557 -767	-18%	-$160K	0.15%	102
2021 Q2	$836K	Hold	4,324	–	–	0.13%	103
2021 Q1	$895K	Hold	4,324	–	–	0.15%	100
2020 Q4	$813K	Hold	4,324	–	–	0.14%	103
2020 Q3	$558K	Hold	4,324	–	–	0.1%	111
2020 Q2	$376K	Hold	4,324	–	–	0.07%	125
2020 Q1	$261K	Hold	4,324	–	–	0.06%	133
2019 Q4	$321K	Hold	4,324	–	–	0.06%	142
2019 Q3	$264K	Hold	4,324	–	–	0.05%	156
2019 Q2	$262K	Hold	4,324	–	–	0.05%	165
2019 Q1	$246K	Hold	4,324	–	–	0.04%	170
2018 Q4	$183K	Hold	4,324	–	–	0.04%	188
2018 Q3	$182K	Buy	+4,324	New	+$203K	0.02%	200

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Silvant Capital Management's INSP Position: Q4 2023 in Review

Silvant Capital Management sold out of Inspire Medical Systems (INSP) in Q4 2023, closing a stake of 7,000 shares — an estimated $1.39M sold.

Silvant Capital Management first reported a position in INSP in Q3 2018 and held it in 21 quarters. The position peaked at $2.27M in Q2 2023. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

Silvant Capital Management reported no remaining Inspire Medical Systems position as of Q4 2023 after selling out during the quarter.
Silvant Capital Management sold 7,000 Inspire Medical Systems shares in Q4 2023, an estimated $1.39M.
Silvant Capital Management first reported a position in Inspire Medical Systems in Q3 2018 and held it in 21 quarters.
Silvant Capital Management's Inspire Medical Systems position peaked at $2.27M in Q2 2023.
343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Silvant Capital Management's 13F filing for Q4 2023, filed 25 Jan 2024.